Ladenburg Thalmann Assumes Novus Therapeutics, Inc (NVUS) at Buy

December 10, 2020 6:57 AM EST Send to a Friend
Ladenburg Thalmann assumes coverage on Novus Therapeutics, Inc (NASDAQ: NVUS) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login